Mosaic ImmunoEngineering (CPMV) Research & Development (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Research & Development of $15880.0 for Q1 2026, little changed year-over-year from $15803.0 in Q1 2025, and down 1.57% quarter-over-quarter from $16133.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Research & Development (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Research & Development history runs 9 years deep, the most recent figure standing at $15880.0 for Q1 2026.
- In Q1 2026, Research & Development changed 0.49% year-over-year to $15880.0; the TTM figure through Mar 2026 stood at $64058.0 (down 51.6% YoY), while the FY2025 annual figure was $63981.0, down 65.2% from the prior year.
- Research & Development for Q1 2026 stood at $15880.0, down from $16133.0 in the prior quarter.
- The five-year high for Research & Development was $327659.0 in Q1 2022, with the low at $15803.0 in Q1 2025.
- The 5-year median for Research & Development is $60707.0 (2024), against an average of $102802.0.
- The sharpest annual moves came in 2022 and 2025: Research & Development jumped 33.11% in 2022, then tumbled 76.52% in 2025.
- Mosaic ImmunoEngineering's Research & Development stood at $207022.0 in 2022, then slumped by 75.85% to $49989.0 in 2023, then sank by 67.49% to $16250.0 in 2024, then slipped by 0.72% to $16133.0 in 2025, then decreased by 1.57% to $15880.0 in 2026.
- Business Quant data shows CPMV's Research & Development at $15880.0 in Q1 2026, $16133.0 in Q4 2025, and $16039.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | 15,880.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,880.00 |
| Dec 31, 2025 | 16,133.00 |
| Sep 30, 2025 | 16,039.00 |
| Jun 30, 2025 | 16,006.00 |
| Mar 31, 2025 | 15,803.00 |
| Dec 31, 2024 | 16,250.00 |
| Sep 30, 2024 | 39,599.00 |
| Jun 30, 2024 | 60,707.00 |
| Mar 31, 2024 | 67,311.00 |
| Dec 31, 2023 | 49,989.00 |
| Sep 30, 2023 | 84,927.00 |
| Jun 30, 2023 | 122,638.00 |
| Mar 31, 2023 | 177,895.00 |
| Dec 31, 2022 | 207,022.00 |
| Sep 30, 2022 | 211,082.00 |
| Jun 30, 2022 | 302,694.00 |
| Mar 31, 2022 | 327,659.00 |
| Dec 31, 2021 | 393,278.00 |
| Sep 30, 2021 | 439,926.00 |
| Jun 30, 2021 | 376,767.00 |